New Drug: Futibatinib for cholangiocarcinoma
|New Drug: Futibatinib for cholangiocarcinoma|
Goyal L, Meric-Bernstam F
Goyal L, Meric-Bernstam F et al. A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions or other rearrangements.
Reviewed by Elvin CHALABİYEV, MD on Jan 30, 2023
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.